Etiopathogenesis of alopecia areata: Why do our patients get it?

被引:45
|
作者
Wang, Eddy [1 ]
McElwee, Kevin J. [1 ,2 ]
机构
[1] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 4E8, Canada
[2] Vancouver Coastal Hlth Res Inst, Vancouver, BC V5Z 4E8, Canada
基金
加拿大健康研究院;
关键词
alopecia areata; autoimmune disease; disease pathogenesis; C3H/HEJ MOUSE MODEL; HELPFUL DIAGNOSTIC FEATURE; HUMAN SCALP EXPLANTS; IN-VIVO DEPLETION; HAIR FOLLICLE; IMMUNE PRIVILEGE; AUTOIMMUNE-DISEASE; T-CELLS; DEBR MODEL; CYTOMEGALOVIRUS DNA;
D O I
10.1111/j.1529-8019.2011.01416.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Alopecia areata (AA) is a nonscarring, inflammatory skin disease that results in patchy hair loss. AA is unpredictable in its onset, severity, and duration making it potentially very stressful for affected individuals. Currently, the treatment options for AA are limited and the efficacy of these treatments varies from patient to patient. The exact etiology of AA is unknown. This article provides some insights into the etiopathogenesis of AA and why some people develop it. The current knowledge on the pathogenesis of AA is summarized and some of the recent hypotheses and studies on AA are presented to allow for a fuller understanding of the possible biological mechanisms of AA.
引用
收藏
页码:337 / 347
页数:11
相关论文
共 50 条
  • [11] Why is alopecia areata most often ''areata'' and not always ''totalis'' or ''universalis''?
    Bodemer, C
    deProst, Y
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1997, 124 (11): : 814 - 815
  • [12] Tattoos: Why do we get? What is our attitude?
    Kayiran, Melek Aslan
    Ozkul, Elif
    Gurel, Mehmet Salih
    TURK DERMATOLOJI DERGISI-TURKISH JOURNAL OF DERMATOLOGY, 2020, 14 (01): : 18 - 22
  • [13] The genetics of alopecia areata: What's new and how will it help our patients?
    Petukhova, Lynn
    Cabral, Rita M.
    Mackay-Wiggan, Julian
    Clynes, Raphael
    Christiano, Angela M.
    DERMATOLOGIC THERAPY, 2011, 24 (03) : 326 - 336
  • [14] Comorbidities in patients with alopecia areata
    Conic, Ruzica Z.
    Miller, Rose
    Piliang, Melissa
    Bergfeld, Wilma
    Mesinkovska, Natasha Atanaskova
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (04) : 755 - 757
  • [15] ANXIETY IN PATIENTS WITH ALOPECIA AREATA
    Kaaz, Karolina
    Puchalska, Agata
    Marcinow, Katarzyna
    Garbowska, Justyna
    Reich, Adam
    Szepietowski, Jacek C.
    ACTA DERMATO-VENEREOLOGICA, 2016, 96 : 137 - 137
  • [16] How Our Microbiome Influences the Pathogenesis of Alopecia Areata
    Sanchez-Pellicer, Pedro
    Navarro-Moratalla, Laura
    Nunez-Delegido, Eva
    Aguera-Santos, Juan
    Navarro-Lopez, Vicente
    GENES, 2022, 13 (10)
  • [17] OUR EXPERIENCE WITH PUVA IN TREATING ALOPECIA-AREATA
    BEANI, JC
    REYMOND, JL
    AMBLARD, P
    LYON MEDICAL, 1981, 246 (17): : 305 - 307
  • [18] Topical immunotherapy with diphenylcyclopropenone for alopecia areata: our experience
    Chiang, N. Y. Z.
    Abdullah, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 : 51 - 51
  • [19] Alopecia areata: why the battle isn’t over
    Laura Vargas-Parada
    Nature, 2021, 595 (7867) : S56 - S56
  • [20] Topical immunotherapy in alopecia areata - What, how, and why?
    Hoffmann, R
    Happle, R
    DERMATOLOGIC CLINICS, 1996, 14 (04) : 739 - &